Jean Nappi to Female
This is a "connection" page, showing publications Jean Nappi has written about Female.
Connection Strength
0.141
-
Barriers to clopidogrel adherence following placement of drug-eluting stents. Ann Pharmacother. 2009 Feb; 43(2):259-67.
Score: 0.018
-
Prevalence of anemia in clinic patients with heart failure and cost analysis of epoetin treatment. Pharmacotherapy. 2007 May; 27(5):707-14.
Score: 0.016
-
Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Pharmacotherapy. 2006 Apr; 26(4):461-8.
Score: 0.015
-
Role of race in the pharmacotherapy of heart failure. Ann Pharmacother. 2002 Mar; 36(3):471-8.
Score: 0.011
-
New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother. 2001 May; 35(5):589-617.
Score: 0.010
-
Myocardial infarction in women: a critical appraisal of gender differences in outcomes. Pharmacotherapy. 2000 Sep; 20(9):1034-44.
Score: 0.010
-
The association of the combination of sumatriptan and methysergide in myocardial infarction in a premenopausal woman. Arch Intern Med. 1999 Mar 08; 159(5):511-3.
Score: 0.009
-
Pharmacy residency training measured through a standardized knowledge test. Am J Health Syst Pharm. 2016 Dec 15; 73(24):2095-2098.
Score: 0.008
-
Possible pharmacokinetic interaction with quinidine: ciprofloxacin or metronidazole? Ann Pharmacother. 1996 Apr; 30(4):364-6.
Score: 0.007
-
Multi-institutional study of women and underrepresented minority faculty members in academic pharmacy. Am J Pharm Educ. 2012 Feb 10; 76(1):7.
Score: 0.006
-
Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother. 2011 Dec; 55(12):5475-9.
Score: 0.005
-
Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail. 2010 Mar; 16(3):188-93.
Score: 0.005
-
Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis. Ann Pharmacother. 2008 Jun; 42(6):904-5.
Score: 0.004
-
Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias. Eur J Clin Pharmacol. 1986; 31(1):15-22.
Score: 0.004
-
Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study. Am J Cardiol. 1984 Feb 01; 53(4):522-7.
Score: 0.003
-
Efficacy of intravenous pirmenol hydrochloride for treatment of ventricular arrhythmias: a controlled comparison with lidocaine. J Cardiovasc Pharmacol. 1983 Mar-Apr; 5(2):213-20.
Score: 0.003
-
Combination antiplatelet therapy: implications for pharmacists. J Am Pharm Assoc (Wash). 2002 Nov-Dec; 42(6):880-3.
Score: 0.003
-
Antihypertensive monotherapy with tablet (prompt-release) diltiazem: multicenter controlled trials. Cardiovasc Drugs Ther. 1990 Aug; 4(4):1089-96.
Score: 0.001
-
Sustained-release diltiazem: duration of antihypertensive effect. J Clin Pharmacol. 1989 Jun; 29(6):533-7.
Score: 0.001
-
Metabolic effects of antihypertensive therapy with a calcium antagonist. Am J Cardiol. 1988 Oct 05; 62(11):109G-113G.
Score: 0.001
-
The disposition of recainam hydrochloride during and after intravenous loading and maintenance infusion in cardiac patients. J Clin Pharmacol. 1987 Dec; 27(12):951-6.
Score: 0.001
-
Individualization of phenytoin dosage regimens. Clin Pharmacol Ther. 1977 Mar; 21(3):287-93.
Score: 0.000